tiprankstipranks
Remgro Limited (RMGOF)
OTHER OTC:RMGOF

Remgro (RMGOF) Price & Analysis

6 Followers

RMGOF Stock Chart & Stats

$12.35
-$1.32(-14.15%)
At close: 4:00 PM EST
$12.35
-$1.32(-14.15%)

RMGOF FAQ

What was Remgro Limited’s price range in the past 12 months?
Remgro Limited lowest stock price was $8.00 and its highest was $13.85 in the past 12 months.
    What is Remgro Limited’s market cap?
    Remgro Limited’s market cap is $6.56B.
      When is Remgro Limited’s upcoming earnings report date?
      Remgro Limited’s upcoming earnings report date is Sep 17, 2026 which is in 93 days.
        How were Remgro Limited’s earnings last quarter?
        Remgro Limited released its earnings results on Mar 25, 2026. The company reported $0.535 earnings per share for the quarter, beating the consensus estimate of N/A by $0.535.
          Is Remgro Limited overvalued?
          According to Wall Street analysts Remgro Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Remgro Limited pay dividends?
            Remgro Limited pays a Semiannually dividend of $0.105 which represents an annual dividend yield of 3.49%. See more information on Remgro Limited dividends here
              What is Remgro Limited’s EPS estimate?
              Remgro Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Remgro Limited have?
              Remgro Limited has 529,217,000 shares outstanding.
                What happened to Remgro Limited’s price movement after its last earnings report?
                Remgro Limited reported an EPS of $0.535 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.532%.
                  Which hedge fund is a major shareholder of Remgro Limited?
                  Currently, no hedge funds are holding shares in RMGOF
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Remgro Limited

                    Remgro Limited operates as a prominent investment holding company, deploying capital across a diverse range of industries. These sectors encompass financial services, food, liquor and home care products, banking, insurance, various industrial activities, healthcare, infrastructure development, information technology infrastructure solutions, media, and sports. Geographically, it targets opportunities primarily within Africa, the UAE, the United Kingdom, and Switzerland, while also expanding its global footprint through its investee companies. A core tenet of its investment strategy is to acquire substantial influence and secure representation on the boards of its portfolio firms. Crucially, Remgro focuses on offering strategic support rather than becoming involved in the day-to-day operational management of the businesses it invests in. Established in 1948, the company is based in Stellenbosch, South Africa.

                    Remgro (RMGOF) Earnings & Revenues

                    RMGOF Company Deck

                    RMGOF Earnings Call

                    Q2 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call conveyed a clearly positive financial and strategic momentum for Remgro: materially stronger headline earnings, materially higher dividends and cash generation, successful completion of key corporate actions (CIVH/Vodacom, BAT sale, FirstRand monetizations) and operational turnarounds at several investees (Mediclinic, CIVH, Rainbow, Heineken Beverages). That said, management flagged meaningful near-term and sector-specific risks — notably RCL Foods’ sugar weakness and industry stress, volatility in Mediclinic’s Middle East operations from geopolitical conflict, valuation sensitives and some modest INAV growth versus earnings. Overall the tone was constructive and confident about execution but realistic about macro and specific operational headwinds.View all RMGOF earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Berkshire Hathaway B
                    Blackstone Group
                    KKR & Co
                    Apollo Global Management
                    Carlyle Group
                    Itau Unibanco
                    Popular Stocks